Placebo-acetazolamide — Competitive Intelligence Brief

Placebo-acetazolamide (Placebo-acetazolamide) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Carbonic anhydrase inhibitor. Area: Ophthalmology.

marketed Carbonic anhydrase inhibitor Carbonic anhydrase Ophthalmology Small molecule

Target snapshot

Placebo-acetazolamide (Placebo-acetazolamide) — Shahid Beheshti University of Medical Sciences. Acetazolamide inhibits carbonic anhydrase to reduce aqueous humor production and intraocular pressure, while the placebo component serves as a control in clinical evaluation.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Placebo-acetazolamide TARGET	Placebo-acetazolamide	Shahid Beheshti University of Medical Sciences	marketed	Carbonic anhydrase inhibitor	Carbonic anhydrase
Sodium Nitrite	SODIUM NITRITE	Hope Pharms	marketed	sodium nitrite	Carbonic anhydrase 1	2011-01-01
Banzel	RUFINAMIDE	Eisai	marketed	rufinamide	Carbonic anhydrase 5A, mitochondrial	2008-01-01
Tri-Luma	HYDROQUINONE	Galderma Labs Lp	marketed	Melanin Synthesis Inhibitor [EPC]	Carbonic anhydrase 2	2002-01-01
Azopt	BRINZOLAMIDE	Novartis	marketed	Carbonic Anhydrase Inhibitor [EPC]	carbonic anhydrase II	1998-01-01
Trusopt	DORZOLAMIDE	Merck & Co.	marketed	Carbonic Anhydrase Inhibitor	Carbonic anhydrase 2	1994-01-01
Fludara	FLUDARABINE PHOSPHATE	Nihon Schering K.K.	marketed	Nucleoside Metabolic Inhibitor	Carbonic anhydrase 5A, mitochondrial	1991-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Carbonic anhydrase inhibitor class)

1. Bausch & Lomb Incorporated · 2 drugs in this class
2. Actavis Inc. · 2 drugs in this class
3. Beijing Tiantan Hospital · 1 drug in this class
4. Merck Sharp & Dohme LLC · 1 drug in this class
5. National University Hospital, Singapore · 1 drug in this class
6. Padagis LLC · 1 drug in this class
7. Rabin Medical Center · 1 drug in this class
8. Shahid Beheshti University of Medical Sciences · 1 drug in this class
9. Sun Pharmaceutical Industries Limited · 1 drug in this class
10. University Health Network, Toronto · 1 drug in this class